Przejdź do zawartości
Merck

Targeted Protein Degradation by Small Molecules.

Annual review of pharmacology and toxicology (2016-10-13)
Daniel P Bondeson, Craig M Crews
ABSTRAKT

Protein homeostasis networks are highly regulated systems responsible for maintaining the health and productivity of cells. Whereas therapeutics have been developed to disrupt protein homeostasis, more recently identified techniques have been used to repurpose homeostatic networks to effect degradation of disease-relevant proteins. Here, we review recent advances in the use of small molecules to degrade proteins in a selective manner. First, we highlight all-small-molecule techniques with direct clinical application. Second, we describe techniques that may find broader acceptance in the biomedical research community that require little or no synthetic chemistry. In addition to serving as innovative research tools, these new approaches to control intracellular protein levels offer the potential to develop novel therapeutics targeting proteins that are not currently pharmaceutically vulnerable.

MATERIAŁY
Numer produktu
Marka
Opis produktu

Sigma-Aldrich
Opto-thalidomide-O-acetamide-C4-NH2 hydrochloride
Sigma-Aldrich
Opto-pomalidomide, ≥95%
Sigma-Aldrich
CCW16, ≥95%
Sigma-Aldrich
3-((4-(Piperidin-4-yl)phenyl)amino)piperidine-2,6-dione hydrochloride, ≥95%
Sigma-Aldrich
Thalidomide-NH-PEG2-COOH, ≥95%
Sigma-Aldrich
CCW16-PEG2-butyl-BocNH, ≥95%
Sigma-Aldrich
CCW16-PEG5-BocNH, ≥95%
Sigma-Aldrich
4-Aminomethyl-2-(2,6-dioxopiperidin-3-yl)isoindole-1,3-dione hydrochloride, ≥95%
Sigma-Aldrich
Pomalidomide-piperazine-C1-4-piperidine hydrochloride
Sigma-Aldrich
1H-Isoindole-1,3(2H)-dione, 2-(2,6-dioxo-3-piperidinyl)-5-(4-piperidinyloxy) hydrochloride, ≥95%
Sigma-Aldrich
Pomalidomide acetic acid, ≥95.0%
Sigma-Aldrich
3-[1,3-Dihydro-4-(5-hydroxy-1-pentyn-1-yl)-1-oxo-2H-isoindol-2-yl]-2,6-piperidinedione, ≥95.0%
Sigma-Aldrich
Pomalidomide 4′-PEG3-amine hydrochloride, ≥95%
Sigma-Aldrich
VH 032 amide-PEG2-acid, ≥95%
Sigma-Aldrich
3-[1,3-Dihydro-4-(4-hydroxy-1-butyn-1-yl)-1-oxo-2H-isoindol-2-yl]-2,6-piperidinedione, ≥95.0%
Sigma-Aldrich
Pomalidomide-PEG2-C2-NH2 hydrochloride, ≥95%
Sigma-Aldrich
6F,C5-Pomalidomide-piperazine-piperidine-4-carbothioamide hydrochloride
Sigma-Aldrich
1H-Isoindole-1,3(2H)-dione, 4-[(4-aminobutyl)amino]-2-(2,6-dioxo-3-piperidinyl)-, hydrochloride, ≥95%
Sigma-Aldrich
Pentanoic acid, 5-[[2-(2,6-dioxo-3-piperidinyl)-2,3-dihydro-1,3-dioxo-1H-isoindol-4-yl]amino]-, ≥95%
Sigma-Aldrich
Pomalidomide-PEG1-C2-amine HCl, ≥95.0%
Sigma-Aldrich
FBnG-C3-PEG3-C3-NH2 hydrochloride, ≥95%
Sigma-Aldrich
(S,R,S)-AHPC-CO-PEG4-C2-amine HCl, ≥95%
Sigma-Aldrich
Carbamic acid, N-[2-(1-piperazinyl)ethyl]-, 1,1-dimethylethyl ester, ≥95%
Sigma-Aldrich
Opto-pomalidomide-C2-NH2 hydrochloride, ≥95%
Sigma-Aldrich
(S,R,S)-AHPC-acetamido-O-PEG2-C1-acid, ≥95%
Sigma-Aldrich
(S,R,S)-VL285 Phenol-piperazine-pyridine-alkyne-NH2 hydrochloride
Sigma-Aldrich
L-Prolinamide, N-[2-[2-(carboxymethoxy)ethoxy]acetyl]-3-methyl-L-valyl-4-hydroxy-N-[[4-(4-methyl-5-thiazolyl)phenyl]methyl]-, (4R)-, ≥95%
Sigma-Aldrich
3-(3-Fluoro-4-piperidin-4-ylphenylamino)piperidine-2,6-dione hydrochloride, ≥95%
Sigma-Aldrich
C5 Lenalidomide-dipiperazine-NH2 hydrochloride
Sigma-Aldrich
Thalidomide-4-hydroxyacetate, ≥95.0%